MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/vaccines13080857

Медицинская библиотека · Vaccines · 2025

Biological Characterization and DIVA Potential of Three Rough Brucella melitensis Vaccine Strains.

Liu Jinyue, Yin Yi, Yang Xinmei, Li Mengsi, Qu Jing, Wang Shaohui, Bao Yanqing, Qi Jingjing, Wu Tonglei, Tian Mingxing

СтатьяПеревод в очереди

Аннотация

Background

Brucellosis is a zoonotic bacterial disease primarily controlled through quarantine, culling, and vaccination. Live attenuated vaccines remain the most effective countermeasure, yet their application is limited by residual virulence and diagnostic interference. This study developed three rough-type attenuated Brucella melitensis mutants (G7, G8, G16) and evaluated their potential as DIVA (Differentiating Infected from Vaccinated Animals) vaccine candidates.

Methods

Rough phenotypes were characterized through heat agglutination, acridine orange staining, and immunoblotting. Macrophage cytotoxicity was assessed via LDH release assays, while RT-qPCR analyzed macrophage activation capacity. Mouse infection and immunization-challenge experiments, complemented by histopathology, evaluated residual virulence and protective immunity. Antibody profiles were determined by ELISA, and DIVA capability was verified using LPS-coated ELISA.

Results

G7 and G8 exhibited complete rough phenotypes, whereas G16 retained partial O-antigen (semi-rough). All rough mutants induced macrophage cytotoxicity and activation. The strains showed attenuated virulence with no viable bacteria recovered from spleens at 4 weeks post-inoculation. Histopathology revealed no liver lesions at 6 weeks post-inoculation. Immunized mice predominantly produced IgG2a-dominated Th1-type responses. The immune protection levels of G7 and G16 matched the reference vaccine M5-90Δ26, while G8 showed slightly lower efficacy. LPS-ELISA effectively differentiated vaccinated from infected animals via concurrent IgM/IgG detection.

Conclusions

This study demonstrates that the rough-type B. melitensis mutants G7 and G16 serve as promising DIVA vaccine candidates, offering strong protection with low residual virulence while enabling serological differentiation between vaccinated and infected animals, highlighting their potential as effective vaccines for brucellosis control.

Для цитирования: Liu Jinyue, Yin Yi, Yang Xinmei, Li Mengsi, Qu Jing, Wang Shaohui, Bao Yanqing, Qi Jingjing, Wu Tonglei, Tian Mingxing. Biological Characterization and DIVA Potential of Three Rough Brucella melitensis Vaccine Strains.. Vaccines. 2025. DOI: 10.3390/vaccines13080857.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.